Articles with "daa treatment" as a keyword



Photo by myriamzilles from unsplash

Risk of hepatocellular carcinoma after DAA treatment in cirrhotic HIV-HCV-coinfected patients: where do we stand?

Sign Up to like & get
recommendations!
Published in 2018 at "AIDS"

DOI: 10.1097/qad.0000000000001823

Abstract: Together with the increase in life expectancy of HIVinfected individuals with antiretroviral therapy (ART), morbidity and mortality from liver disease has sharply increased in individuals coinfected with hepatitis C or B and exhibit advanced liver… read more here.

Keywords: hepatocellular carcinoma; carcinoma; treatment cirrhotic; risk hepatocellular ... See more keywords
Photo by schluditsch from unsplash

Uptake of direct acting antiviral therapies for the treatment of hepatitis C virus among people who inject drugs in a universal health‐care system

Sign Up to like & get
recommendations!
Published in 2019 at "Drug and Alcohol Review"

DOI: 10.1111/dar.12883

Abstract: INTRODUCTION AND AIMS Direct acting antiviral (DAA) treatment can reduce hepatitis C virus (HCV) infection incidence and mortality, although large scale uptake of these treatments is necessary to achieve those reductions. Targeting people who inject… read more here.

Keywords: treatment; direct acting; acting antiviral; hepatitis virus ... See more keywords
Photo by schluditsch from unsplash

The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of managed care & specialty pharmacy"

DOI: 10.18553/jmcp.2021.27.7.873

Abstract: BACKGROUND: There is evidence that barriers exist for the initiation of direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) for those with substance use disorders (SUDs). However, real world clinical evidence of DAA treatment… read more here.

Keywords: infected patients; treatment; daa treatment; treatment initiation ... See more keywords
Photo by schluditsch from unsplash

Safety and Efficacy of Direct Antiviral Agents for Hepatitis C in Patients with Malignancies Other Than Liver Cancer: A Case Series

Sign Up to like & get
recommendations!
Published in 2022 at "Pathogens"

DOI: 10.3390/pathogens11080860

Abstract: (1) Background: direct-acting antivirals (DAA) are the current standard of care for chronic hepatitis C. Oncologic patients remain among the most difficult-to-treat subgroups of hepatitis C virus (HCV)-infected patients due to their clinical frailty and… read more here.

Keywords: chronic hepatitis; safety efficacy; daa treatment; hepatitis ... See more keywords